Your browser doesn't support javascript.
Dysregulation of Innate and Adaptive Immune Responses in Asymptomatic SARS-CoV-2 Infection with Delayed Viral Clearance.
Cao, Shanshan; Zhang, Qing; Song, Liu; Xiao, Mingzhong; Chen, Yexing; Wang, Dianbing; Li, Min; Hu, Jinchao; Lin, Lin; Zheng, Ying; Zhou, Kun; Ye, Shujian; Zhou, Juan; Zhou, Ya Na; Cui, Jing; Wang, Jingzhi; Sun, Jing; Tao, Junxiu; Chen, Zhou; Chen, Rong; Zhou, Peng; Shi, Zhengli; Wei, Sheng; Zhao, Linhua; Wang, Hui; Tong, Xiaoling; Li, Xiaodong; Men, Dong; Hou, Baidong; Zhang, Xian-En.
  • Cao S; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China.
  • Zhang Q; University of Chinese Academy of Sciences, Beijing 100049, China.
  • Song L; Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan 430074, China.
  • Xiao M; National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
  • Chen Y; University of Chinese Academy of Sciences, Beijing 100049, China.
  • Wang D; Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan 430074, China.
  • Li M; National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
  • Hu J; University of Chinese Academy of Sciences, Beijing 100049, China.
  • Lin L; National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
  • Zheng Y; National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
  • Zhou K; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China.
  • Ye S; National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
  • Zhou J; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China.
  • Zhou YN; University of Chinese Academy of Sciences, Beijing 100049, China.
  • Cui J; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China.
  • Wang J; University of Chinese Academy of Sciences, Beijing 100049, China.
  • Sun J; National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
  • Tao J; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China.
  • Chen Z; University of Chinese Academy of Sciences, Beijing 100049, China.
  • Chen R; Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan 430074, China.
  • Zhou P; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China.
  • Shi Z; Hubei University, Wuhan 430074, China.
  • Wei S; Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan 430074, China.
  • Zhao L; Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan 430074, China.
  • Wang H; Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan 430074, China.
  • Tong X; Wuchang District Hospital of Traditional Chinese Medicine, Wuhan 430060, China.
  • Li X; Jiyuqiao Street Community Health Service Center, Wuchang District, Wuhan 430081, China.
  • Men D; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China.
  • Hou B; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China.
  • Zhang XE; Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Int J Biol Sci ; 18(12): 4648-4657, 2022.
Article in English | MEDLINE | ID: covidwho-1954693
ABSTRACT
Asymptomatic infection with SARS-CoV-2 is a major concern in the control of the COVID-19 pandemic. Many questions concerning asymptomatic infection remain to be answered, for example, what are the differences in infectivity and the immune response between asymptomatic and symptomatic infections? In this study, based on a cohort established by the Wuchang District Health Bureau of Wuhan in the early stage of the COVID-19 pandemic in Wuhan in 2019, we conducted a comprehensive analysis of the clinical, virological, immunological, and epidemiological data of asymptomatic infections. The major findings of this study included 1) the asymptomatic cohort enrolled this study exhibited low-grade but recurrent activity of viral replication; 2) despite a lack of overt clinical symptoms, asymptomatic infections exhibited ongoing innate and adaptive immune responses; 3) however, the immune response from asymptomatic infections was not activated adequately, which may lead to delayed viral clearance. Given the fragile equilibrium between viral infection and host immunity, and the delayed viral clearance in asymptomatic individuals, close viral monitoring should be scheduled, and therapeutic intervention may be needed.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Language: English Journal: Int J Biol Sci Journal subject: Biology Year: 2022 Document Type: Article Affiliation country: Ijbs.72963

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Language: English Journal: Int J Biol Sci Journal subject: Biology Year: 2022 Document Type: Article Affiliation country: Ijbs.72963